MKI67 and breast neoplasm: In a randomized placebo‐controlled clinical trial on postmenopausal women, Palomares et al. (2004) showed that isoflavone containing tablets significantly reduced Ki‐67 proliferation marker in breast tumor biopsies (Palomares et al., 2004).